SPEAKER: Dr. Terry J. Fry, M.D.

SPEAKER BIO: Dr. Fry is a Professor of Pediatrics, Hematology and Immunology, Co-Director of the Human Immunology and Immunotherapy Initiative, Director of Cancer Immunotherapy at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado.  He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia.  Prior to the NIH, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington, DC.  Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers.  He serves on the Committee for Scientific Affairs for the American Society of Hematology, Vice Chair for Biology in the Cellular Therapy Committee of the Children’s Oncology Group and was recently elected into the American Society for Clinical Investigation.

ABSTRACT: Dr. Fry is an international expert in the development of cellular therapies for the management of children with cancer, with an emphasis on acute leukemia.  He will present work from his laboratory that will inform translation of new cellular therapies into pediatric clinical trials.  He will also provide translational data that addresses the issue of duration of response and mechanism of resistance to cellular therapies.

LIVE WEBCAST:  https://externalmediasite.partners.org/Mediasite/Play/a46012e230fe42229252e4275e05008d1d

PARKING: Please park in the Yawkey Garage, P3 or lower. Write “WS” on the back of your parking ticket and parking will be free upon your exit.